CClinicalTrials.gg
Not yet recruitingNCT07151404Updated Sep 3, 2025

Efficacy of Acupuncture at Lieque (LU7) for Neck Pain in Cervical Spondylosis

An interventional study of Acupuncture at LU7 (Lieque) + Electroacupuncture and Electroacupuncture Only in Cervical Spondylosis and Neck Pain, sponsored by Nguyen Ngoc Doan Thuy. Not yet recruiting at 1 site in Vietnam. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-09-03.

Sponsored by Nguyen Ngoc Doan Thuy · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

Cervical spondylosis is a common degenerative disorder of the cervical spine that often leads to chronic neck pain, stiffness, and reduced daily functioning. Pain management in these patients remains challenging, and acupuncture is widely used as a non-pharmacological treatment option. However, the additional benefit of stimulating the Lieque (LU7) acupoint, based on the Six Command Points theory, has not been fully established.

This randomized controlled trial will evaluate whether acupuncture at Lieque (LU7), combined with electroacupuncture at Jiaji (Ex-B2, C4-C7) and cervical-shoulder points, provides greater pain relief compared to electroacupuncture at Jiaji (Ex-B2, C4-C7) and cervical-shoulder points alone.

A total of 130 participants with cervical spondylosis will be randomly assigned to two groups. Treatments will be delivered over 20 days. The primary outcome is the change in neck pain intensity, measured by a 0-100 mm Visual Analog Scale (VAS), from baseline to the end of treatment.

The findings will provide clinical evidence on the effectiveness of acupuncture at Lieque (LU7) for reducing neck pain and improving patient outcomes in cervical spondylosis.

02

Conditions studied

  • Cervical Spondylosis
  • Neck Pain

Keywords

  • Cervical Spondylosis
  • Neck Pain
  • Cervical Spine
  • Acupuncture
  • Electroacupuncture
  • Lieque Point
  • LU7 Acupoint
  • Jiaji Points
  • Cervical-Shoulder Acupoints
  • Randomized Controlled Trial
  • LU7
  • Ex-B2
  • Ex-B2, C4-C7
03

In context

Spondylosis

144 studies on the registry are indexed under Spondylosis; 41 are open to participants now.

This study's planned enrollment of 130 is above the median of 60 across 99 interventional studies indexed under Spondylosis.

Browse Spondylosis studies →

Lead sponsor

This is the only study on the registry with Nguyen Ngoc Doan Thuy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 40 years or older
  • Diagnosis of cervical spondylosis based on clinical evaluation and imaging.
  • Presence of cervical spine syndrome, including:

    • Neck and shoulder pain.
    • Limited range of motion in the cervical spine.
    • Local tenderness over the cervical spine or paraspinal region corresponding to nerve roots.
  • Radiographic evidence of cervical spondylosis on standard X-ray (frontal, lateral, or oblique views), showing one or more of the following:

    • Subchondral sclerosis.
    • Narrowing of the intervertebral disc space.
    • Osteophyte formation (bone spurs, bridging osteophytes).
  • Patients receiving treatment at Thu Duc City Hospital

Exclusion criteria

Exclusion Criteria:

  • Patients who do not agree to participate in the study.
  • Acute torticollis, cervical disc herniation, spinal deformity, cervical spine trauma, or spinal tumors.
  • Neck and shoulder pain not caused by cervical spondylosis.
  • History of systemic diseases such as rheumatoid arthritis, severe cardiovascular disease, systemic infection, malignancy, or immunodeficiency disorders.
  • History of neurological or psychiatric conditions that impair communication or compliance, including speech disorders, impaired consciousness, psychosis, or dementia.
  • Contraindications to electroacupuncture.
  • Non-compliance with study treatment protocol.
  • Use of non-steroidal anti-inflammatory drugs (NSAIDs) within the past 10 days or local corticosteroid injection within the past 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Lieque (LU7) + Electroacupuncture

    Participants will receive filiform needle acupuncture at Lieque (LU7) combined with electroacupuncture at Jiaji (Ex-B2, C4-C7) and neck-shoulder acupoints. Sterile disposable filiform needles (0.3 × 25 mm) will be used. Electroacupuncture will be applied at 60 Hz continuous wave for 30 minutes per session. Treatment will be given once daily for a total of 20 sessions, excluding Sundays (approximately 4 weeks).

    Procedure: Acupuncture at LU7 (Lieque) + Electroacupuncture

  • Active comparator
    Electroacupuncture Only

    Participants will receive electroacupuncture at Jiaji (Ex-B2, C4-C7) and neck-shoulder acupoints only, without acupuncture at Lieque (LU7). Electroacupuncture will be applied at 60 Hz continuous wave for 30 minutes per session. Treatment will be given once daily for a total of 20 sessions, excluding Sundays (approximately 4 weeks).

    Procedure: Electroacupuncture Only

Interventions

  • ProcedureAcupuncture at LU7 (Lieque) + Electroacupuncture

    Participants will receive filiform needle acupuncture at Lieque (LU7) combined with electroacupuncture at Jiaji (Ex-B2, C4-C7) and neck-shoulder acupoints including Fengchi (GB20), Jianjing (GB21), Tianzhu (BL10), and Dazhu (BL11). Sterile disposable filiform needles (0.3 × 25 mm) will be inserted at LU7 using standard manual acupuncture technique. Electroacupuncture will be delivered with continuous wave stimulation at 60 Hz for 30 minutes per session. Treatment will be performed once daily for a total of 20 sessions over approximately 4 weeks, excluding Sundays.

    Also known as: Filiform Needle Acupuncture at Lieque (LU7), Filiform Needle Acupuncture at LU7, Filiform Needle Acupuncture

  • ProcedureElectroacupuncture Only

    Participants will receive electroacupuncture at Jiaji (Ex-B2, C4-C7) and neck-shoulder acupoints including Fengchi (GB20), Jianjing (GB21), Tianzhu (BL10), and Dazhu (BL11), without acupuncture at Lieque (LU7). Electroacupuncture will be delivered with continuous wave stimulation at 60 Hz for 30 minutes per session. Treatment will be performed once daily for a total of 20 sessions over approximately 4 weeks, excluding Sundays.

    Also known as: Electroacupuncture, Electroacupuncture Control, EA at Jiaji and Neck-Shoulder Acupoints, EA, Electroacupuncture at Jiaji and Neck-Shoulder Acupoints

06

What researchers measure

Primary outcomes

  1. Change in Neck Pain Intensity (VAS Score)

    Pain intensity in the neck region will be assessed using a 100-mm Visual Analogue Scale (VAS), where 0 mm = no pain and 100 mm = worst possible pain.

    Time frame: Baseline (D0), Day 10 (D10), and Day 20 (D20).

Secondary outcomes

  1. Change in Neck Pain Questionnaire (NPQ) Score

    The NPQ (8-item version) will be used to assess disability related to neck pain. It covers 8 domains: pain intensity, pain and sleep, nocturnal paresthesia, duration of symptoms, carrying objects, reading/TV, work/housework, and social activities. Each domain is scored 0-4; total score ranges from 0 (no disability) to 32 (severe disability). Higher scores indicate greater disability.

    Time frame: Baseline (D0), Day 10 (D10), and Day 20 (D20).

  2. Change in Cervical Range of Motion (ROM)

    Cervical spine ROM (flexion, extension, right/left lateral flexion, right/left rotation) will be measured in degrees using a goniometer (or inclinometer). Higher values indicate greater mobility.

    Time frame: Baseline (D0), Day 10 (D10), and Day 20 (D20).

Other outcomes

  1. Adverse Events Related to Acupuncture/Electroacupuncture

    All adverse events will be systematically recorded, including but not limited to: nausea, fatigue, dizziness, heavy numbness of the limbs, and other unexpected events. Each event will be assessed for severity (mild, moderate, severe) and its possible relationship to the intervention.

    Time frame: Throughout the 20 treatment sessions (approximately 4 weeks).

  2. Distribution of Traditional Chinese Medicine (TCM) Syndrome Types

    Participants will be classified into Traditional Chinese Medicine (TCM) syndromes according to TCM diagnostic criteria: Wind-Cold-Damp Bi Syndrome (WCDBS) Wind-Damp-Heat Bi Syndrome (WDHBS) Qi Stagnation and Blood Stasis (QSBS) Liver and Kidney Yin Deficiency (LKYD) The frequency and proportion of each syndrome type will be recorded.

    Time frame: At baseline (D0), prior to intervention.

07

Study locations

1 site
  • Thu Duc City Hospital
    Ho Chi Minh City, Ho Chi Minh 700000, Vietnam
    • Ngoc Doan Thuy Nguyen, MD, MSc · Contact · nndthuy@uhsvnu.edu.vn · +84-918-949-394
    • Ngoc Doan Thuy Nguyen, MD, MSc · Contact · nguyenngocdoanthuy@outlook.com · +84-918-949-394
    • Ngoc Doan Thuy Nguyen, MD, MSc · Principal investigator
    • Xuan Sy Truong, MD · Sub investigator
    • Van Dinh Le, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to concerns regarding data confidentiality and patient privacy.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07151404
Lead sponsor
Nguyen Ngoc Doan Thuy
Responsible party
Nguyen Ngoc Doan Thuy (MSc, MD, Lecturer, Department of Acupuncture, School of Medicine - Vietnam National University at Ho Chi Minh City, School of Medicine - Vietnam National University at Ho Chi Minh city) — Sponsor-investigator
First posted
Sep 3, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Sep 3, 2025

Study contacts

Ngoc Doan Thuy Nguyen, MD, MSc
Contact
nndthuy@uhsvnu.edu.vn
+84-918-949-394
Ngoc Doan Thuy Nguyen, MD, MSc
Contact
nguyenngocdoanthuy@outlook.com
+84-918-949-394
Ngoc Doan Thuy Nguyen, MD, MSc
principal investigator · The University of Health Sciences, VNU-HCM

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion